Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Jul 26, 2022

Dr. Matt Wilson is the Founder and CEO of uMEd, bringing together healthcare providers and researchers to reach out to patients to participate in clinical trials.  Using health data, uMed facilitates targeting good candidates for trials and helps the care provider educate patients about the value of participating in one or multiple clinical trials. In a very repeatable and scalable environment, uMed can match patients to specific study opportunities based on standardized queries.

Matt explains, "A lot of other organizations in the clinical study space that are looking at using health record data are using it in a very different way because they're generally focused on bringing together existing EMR data or claims data from lots of different healthcare providers and using that in of itself to identify trends and value for researchers. Whereas uMed is taking a different approach, saying, "Well, actually, their health record data is incredibly useful as a starting point to be able to identify potential study participants."

"We essentially have a common data infrastructure that sits across our network of healthcare providers, that's bound to the U.K. and now the U.S. as well, which will shortly be coming online. What we do in that network is each of these providers essentially say, "Yes, we want to be part of the uMed network." That allows us to be able to bring the data from those health records and normalize them across all of the different providers we're working with."

#uMed #PatientRecruitment #ClinicalTrials #MedicalResearch #ClinicalTrialRecruitment

uMed.io

Listen to the podcast here

uMed